254 related articles for article (PubMed ID: 23901115)
1. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
Gartner JJ; Parker SC; Prickett TD; Dutton-Regester K; Stitzel ML; Lin JC; Davis S; Simhadri VL; Jha S; Katagiri N; Gotea V; Teer JK; Wei X; Morken MA; Bhanot UK; ; Chen G; Elnitski LL; Davies MA; Gershenwald JE; Carter H; Karchin R; Robinson W; Robinson S; Rosenberg SA; Collins FS; Parmigiani G; Komar AA; Kimchi-Sarfaty C; Hayward NK; Margulies EH; Samuels Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13481-6. PubMed ID: 23901115
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.
Adamopoulos PG; Kontos CK; Tsiakanikas P; Scorilas A
Cancer Lett; 2016 Apr; 373(1):119-129. PubMed ID: 26797417
[TBL] [Abstract][Full Text] [Related]
3. Histone acetyltransferase 1 up regulates Bcl2L12 expression in nasopharyngeal cancer cells.
Miao BP; Zhang RS; Yang G; Sun JJ; Tang YY; Liang WF; Liu T; Wen Z; Yang PC; Nie GH
Arch Biochem Biophys; 2018 May; 646():72-79. PubMed ID: 29621521
[TBL] [Abstract][Full Text] [Related]
4. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
[TBL] [Abstract][Full Text] [Related]
5. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.
Jin L; Hu WL; Jiang CC; Wang JX; Han CC; Chu P; Zhang LJ; Thorne RF; Wilmott J; Scolyer RA; Hersey P; Zhang XD; Wu M
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15840-5. PubMed ID: 21896753
[TBL] [Abstract][Full Text] [Related]
7. Cell type-dependent proapoptotic role of Bcl2L12 revealed by a mutation concomitant with the disruption of the juxtaposed Irf3 gene.
Nakajima A; Nishimura K; Nakaima Y; Oh T; Noguchi S; Taniguchi T; Tamura T
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12448-52. PubMed ID: 19617565
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells.
Taghavi MS; Akbarzadeh A; Mahdian R; Azadmanesh K; Javadi G
In Vitro Cell Dev Biol Anim; 2013 Jun; 49(6):465-72. PubMed ID: 23708917
[TBL] [Abstract][Full Text] [Related]
9. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A
Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122
[TBL] [Abstract][Full Text] [Related]
10. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C
PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925
[TBL] [Abstract][Full Text] [Related]
12. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
Stegh AH; Kesari S; Mahoney JE; Jenq HT; Forloney KL; Protopopov A; Louis DN; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10703-8. PubMed ID: 18669646
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Kontos CK; Scorilas A
Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
[TBL] [Abstract][Full Text] [Related]
14. Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
Stegh AH; DePinho RA
Cell Cycle; 2011 Jan; 10(1):33-8. PubMed ID: 21200141
[TBL] [Abstract][Full Text] [Related]
15. Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.
Stegh AH; Brennan C; Mahoney JA; Forloney KL; Jenq HT; Luciano JP; Protopopov A; Chin L; Depinho RA
Genes Dev; 2010 Oct; 24(19):2194-204. PubMed ID: 20837658
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12.
Floros KV; Thomadaki H; Lallas G; Katsaros N; Talieri M; Scorilas A
Ann N Y Acad Sci; 2003 Dec; 1010():153-8. PubMed ID: 15033711
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells.
Rudolf E; Rudolf K; Cervinka M
Apoptosis; 2011 Nov; 16(11):1165-76. PubMed ID: 21809047
[TBL] [Abstract][Full Text] [Related]
18. Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.
Wong SQ; Behren A; Mar VJ; Woods K; Li J; Martin C; Sheppard KE; Wolfe R; Kelly J; Cebon J; Dobrovic A; McArthur GA
Oncotarget; 2015 Jan; 6(2):1115-27. PubMed ID: 25544760
[TBL] [Abstract][Full Text] [Related]
19. Complex transcriptional regulation of the BCL2L12 gene: Novel, active promoter in K562 cells.
Nikcevic G; Drazilov SS; Djurasevic TK; Tosic N; Kontos CK; Scorilas A; Pavlovic S
Gene; 2020 Aug; 750():144723. PubMed ID: 32387119
[TBL] [Abstract][Full Text] [Related]
20. High-throughput resequencing of target-captured cDNA in cancer cells.
Ueno T; Yamashita Y; Soda M; Fukumura K; Ando M; Yamato A; Kawazu M; Choi YL; Mano H
Cancer Sci; 2012 Jan; 103(1):131-5. PubMed ID: 21929543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
